Worst performer was IPX:Impax Asset Management which dropped 14% after final results. I don't understand, as the share price was massively hammered when they lost the St James's Place contract, and the figures were based on no longer having that contract, so they have been hammered twice for the same news. My main holding is now down 67% and my recent purchase is already down 22%.
SBTX:SkinBioTherapeutics results were predictably hopeless and the share price dropped by 11% back to where it was before a recent steady climb.
TLOU:Tlou Energy dropped 10% in the usual massive yo-yo.
BOKU:Boku dropped 8% for no obvious reason and have now slipped to a 2% loss.
PAF:Pan African Resources had a good week, climbing 6% to go 247% up.
GGP:Greatland Resources also had a good week, climbing 8% to go 49% up.
Share of the week is AFC:AFC Energy which climbed 10% and my holding is now only 37% down, which is significantly better than just a few weeks ago. A respected pundit has tipped them as a potential 10-bagger which helped. I hope he's right.
Here's the ISA and shares portfolio after week 19 of year 11.
| Weekly Change | |||
| Cash | £87.11 | -£3.75 | |
| Portfolio cost | £116,758.09 | +£0 | |
| Portfolio sell value (bid price-commission) | £34,791.44 | (-70.2%) | -£919.49 |
| Potential profits | £117.51 | -£81.38 | |
| Yr 11 Dividends | £25.32 | +£0 | |
| Yr 11 Interest | £0.75 | +£0 | |
| Yr 11 Profit from sales | £487.56 | +£0 | |
| Yr 11 proj avg monthly profit | £109.04 | (1.5%) | -£6.96 |
| Total Dividends | £12,513.39 | +£0 | |
| Total Interest | £9.32 | +£0 | |
| Total Profit from sales | £18,047.83 | +£0 | |
| Average monthly cash profit | £240.94 | (3.3%) | -£0.47 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash went down due to ISA fees, and big drop in value thanks to JLP:Jubilee Metals and SBTX:SkinBioTherapeutics. With none of my profitable shares increasing and BOKU:Boku having a big drop, potential profits fell by £81.
The slide continues
Sticking with that trend line
The SIPP looks like this after week 523 overall and week 3 of year 11.
| Weekly Change | ||||
| Cash | £1,350.37 | +£233.34 | ||
| Portfolio cost | £143,096.38 | +£0 | ||
| Portfolio sell value (bid price - commission) | £77,975.89 | (-45.5%) | +£436.00 | |
| Potential profits | £8,910.90 | +£1,009.88 | ||
| Yr 11 Dividends | £35.20 | +£0 | ||
| Yr 11 Interest | £0 | +£0 | ||
| Yr 11 Profit from sales | £800.74 | +£0 | ||
| Yr 11 proj avg monthly profit | £1,183.21 | (15.3%) | -£627.80 | |
| Total Dividends | £18,255.40 | +£0 | ||
| Total Interest | £20.70 | +£0 | ||
| Total Profit from sales | £25,467.25 | +£0 | ||
| Average monthly cash profit | £348.87 | (4.5%) | -£0.80 |
Cash increased due to the arrival of my £250 monthly investment money, minus monthly SIPP fees. Value increased by £436 despite some big drops, and potential profits went up by over £1,000 thanks to a 4% rise in CAML:Central Asia Metals, 4% for KNOS:Kainos Group and the big rises in GGP:Greatland Resources and PAF:Pan African Resources.
Year 11 projected performance is skewed by last week's sale, so will drop dramatically over the next few weeks. TRX:Tissue Regenix announced they are de-listing and granting an epic number of shares to an existing investor to bail them out, which will make my shares utterly worthless. I'll lose £3,437 which will hammer my year 11 and long term performance, so I really need to sell enough to make £2,600 profit to balance out the loss for year 11. I'm reluctant to lose some of my more profitable shares though, so I may just take the hit for now and hope JLP:Jubilee Metals sorts itself out so I can plug the gap.
Great to see that gap closing, but very slowly.
Just above the trend line.
This is going to be ruined when I recognise the TRX:Tissue Regenix loss.
So, this first week in December has failed to deliver a Santa rally as my portfolio has dropped in value. At the moment I can't see where any rally is going to come from, as my biggest holdings are still drifting downwards. At least CAML:Central Asia Metals is staging a bit of a recovery as that's my 4th biggest holding. RIO:Rio Tinto is my 6th biggest, and that's now in profit and sneaking up too. Unfortunately OPTI:Optibiotix, JLP:Jubilee Metals and PBX:Probiotix Health are my top 3 and they are utterly hopeless, and SBTX:SkinBioTherapeutics is 5th and that is going downwards.
Great to see that gap closing, but very slowly.
Just above the trend line.
This is going to be ruined when I recognise the TRX:Tissue Regenix loss.
So, this first week in December has failed to deliver a Santa rally as my portfolio has dropped in value. At the moment I can't see where any rally is going to come from, as my biggest holdings are still drifting downwards. At least CAML:Central Asia Metals is staging a bit of a recovery as that's my 4th biggest holding. RIO:Rio Tinto is my 6th biggest, and that's now in profit and sneaking up too. Unfortunately OPTI:Optibiotix, JLP:Jubilee Metals and PBX:Probiotix Health are my top 3 and they are utterly hopeless, and SBTX:SkinBioTherapeutics is 5th and that is going downwards.
